| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $384.1M | +49.6% |
| Cost of Revenue | $303.3M | +33.3% |
| Gross Profit | $80.8M | +175.1% |
| R&D Expense | $12.2M | +5.2% |
| SG&A Expense | $176.9M | +25.3% |
| Operating Income | -$110.7M | +15.9% |
| Interest Expense | $9.8M | — |
| Pre-tax Income | -$100.6M | +22.0% |
| Income Tax | -$5.1M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $151.0M | +28.8% |
| Accounts Receivable | $38.6M | -15.7% |
| Current Assets | $296.5M | +44.4% |
| Total Assets | $964.8M | +20.0% |
| Current Liabilities | $135.3M | +21.5% |
| Long-term Debt | $206.5M | — |
| Total Liabilities | $578.9M | +60.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.7M | -6.5% |
| Capital Expenditures | $116.7M | +23.1% |
| Investing Cash Flow | -$116.7M | -23.5% |
| Financing Cash Flow | $214.6M | +1539.4% |
| Free Cash Flow | -$124.4M | -21.9% |
| -124.6% |
| Net Income | -$41.6M | +6.2% |
| EPS (Basic) | -$0.31 | +24.4% |
| EPS (Diluted) | -$0.31 | +24.4% |
| Stockholders' Equity |
| -$116.9M |
| +54.4% |